DOI QR코드

DOI QR Code

Designing Inhibitor against Phospholipases A2 Enzyme through Inslico-Molecular Docking Studies

  • Received : 2014.06.14
  • Accepted : 2014.09.25
  • Published : 2014.09.30

Abstract

Pyrazole, hydroxyimino, aldehyde and isoxazole derivatives exhibit a broad spectrum of biological activities such as antimicrobial, anti-inflammatory and antitumor activities. With growing application on their synthesis and bioactivity, chemists and biologists in recent years have considerable attention on the research of these derivatives. In the view of potential importance of these derivatives, we have crystallized few of the derivatives and its report has been published. The present study focuses on docking studies of these derivatives against Phospholipases $A_2$ enzyme. This enzymes has implicated as potential targets for anti-inflammatory drug design. co-crystal structure (PDB ID: 1POE) of $PLA_2$ deposited in Protein Data Bank has been retrieved for docking analysis. Docking studies using Schrodinger's GLIDE reveals that these derivatives shows better binding energy and score in the defined active site. These results may provide a guiding role to design a lead molecule which may reduce inflamation.

Keywords

References

  1. E. A. Dennis, "Diversity of group types, regulation, and function of phospholipase $A_2$", J. Biol. Chem., Vol. 269, pp. 13057-13060, 1994.
  2. J. P. Nicolas, Y. Lin, G. Lambeau, F. Ghomashchi, M. Lazdunski, and M. H. Gelb, "Localization of structural elements of bee venom phospholipase $A_2$ involved in N-type receptor binding and neurotoxicity", J. Biol. Chem., Vol. 272, pp. 7173-7181, 1997. https://doi.org/10.1074/jbc.272.11.7173
  3. A. Argiolas and J. J. Pisano, "Facilitation of phospholipase $A_2$ activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom", J. Biol. Chem., Vol. 258, pp. 13697-13702, 1983.
  4. D. L. Nelson, A. L. Lehninger, and M. M. Cox, "Lehninger principles of biochemistry", Macmillan, 2008.
  5. D. A. Six and E. A. Dennis, "The expanding superfamily of phospholipase A(2) enzymes: classification and characterization", Biochim. Biophys. Acta, Vol. 1488, pp. 1-19, 2000. https://doi.org/10.1016/S1388-1981(00)00105-0
  6. H. Sato, Y. Taketomi, Y. Isogai, Y. Miki, K. Yamamoto, S. Masuda, T. Hosono, S. Arata, Y. Ishikawa, T. Ishii, T. Kobayashi, H. Nakanishi, K. Ikeda, R. Taguchi, S. Hara, I. Kudo, and M. Murakami, "Group III secreted phospholipase $A_2$ regulates epididymal sperm maturation and fertility in mice", J. Clin. Invest., Vol. 120, pp. 1400-1414, 2010. https://doi.org/10.1172/JCI40493
  7. J. Escoffier, I. Jemel, A. Tanemoto, Y. Taketomi, C. Payre, C. Coatrieux, H. Sato, K. Yamamoto, S. Masuda, K. Pernet-Gallay, V. Pierre, S. Hara, M. Murakami, M. De Waard, G. Lambeau, and C. Arnoult, "Group X phospholipase $A_2$ is released during sperm acrosome reaction and controls fertility outcome in mice", J. Clin. Invest., Vol. 120, pp. 1415-1428, 2010. https://doi.org/10.1172/JCI40494
  8. Z. Mallat, G. Lambeau, and A. Tedgui, "Lipoproteinassociated and secreted phospholipases $A_2$ in cardiovascular disease: roles as biological effectors and biomarkers", Circulation, Vol. 122, pp. 2183-2200, 2010. https://doi.org/10.1161/CIRCULATIONAHA.110.936393
  9. W. R. Jr. Henderson, R. C. Oslund, J. G. Bollinger, X. Ye, Y. T. Tien, J. Xue, and M. H. Gelb, "Blockade of human group X secreted phospholipase $A_2$ (GX-sPL$A_2$)-induced airway inflammation and hyper responsiveness in a mouse asthma model by a selective GX-sPL$A_2$ inhibitor", J. Biol. Chem., Vol. 286, pp. 28049-28055, 2011. https://doi.org/10.1074/jbc.M111.235812
  10. Y. Wei, S. P. Epstein, S. Fukuoka, N. P. Birmingham, X. M. Li, P. and A. Asbell, "sPL$A_2$-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model", Invest. Ophth. Vis. Sci., Vol. 52, pp. 4780-4788, 2011. https://doi.org/10.1167/iovs.10-6350
  11. S. Chalbot, H. Zetterberg, K. Blennow, T. Fladby, N. Andreasen, I. Grundke-Iqbal, and K. Iqbal, "Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease", J. Alzheimers dis., Vol. 25, pp. 505-515, 2011.
  12. D. G. Tew, C. Southan, S. Q. Rice, M. P. Lawrence, H. Li, H. F. Boyd, K. Moores, I. S. Gloger, and C. H. Macphee, "Purification, properties, sequencing, and cloning of a lipoprotein-associated, serinedependent phospholipase involved in the oxidative modification of low-density lipoproteins", Arterioscler. Thromb. Vasc. Biol., Vol. 16, pp. 591-599, 1996. https://doi.org/10.1161/01.ATV.16.4.591
  13. L. W. Tjoelker, C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Le Trong, L. S. Cousens, and G.A. Zimmerman, "Antiinflammatory properties of a platelet-activating factor acetylhydrolase", Nature, Vol. 374, pp. 549-553, 1995. https://doi.org/10.1038/374549a0
  14. A. Zalewski and C. Macphee, "Role of lipoproteinassociated phospholipase $A_2$ in atherosclerosis: biology, epidemiology, and possible therapeutic target", Arterioscler. Thromb. Vasc. Biol., Vol. 25, pp. 923-931, 2005. https://doi.org/10.1161/01.ATV.0000160551.21962.a7
  15. Version, Glide. "5.5, Schrodinger." LLC, New York, NY, 716, 2009.